RBF Capital’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,229
Closed -$31K 383
2017
Q4
$31K Buy
+3,229
New +$32.5K ﹤0.01% 374
2017
Q1
Sell
-3,000
Closed -$45K 375
2016
Q4
$45K Hold
3,000
0.01% 362
2016
Q3
$49K Sell
3,000
-937
-24% -$15.4K 0.01% 357
2016
Q2
$63K Hold
3,937
0.01% 355
2016
Q1
$100K Buy
3,937
+90
+2% +$2.77K 0.02% 330
2015
Q4
$125K Buy
+3,847
New +$144K 0.02% 334
2014
Q1
Sell
-5,293
Closed -$414K 287
2013
Q4
$414K Buy
+5,293
New +$431K 0.1% 171

Other funds holding HHS

RBF Capital's HHS Position: Q1 2018 in Review

RBF Capital sold out of Harte-Hanks (HHS) in Q1 2018, closing a stake of 3,229 shares — an estimated $31K sold.

RBF Capital first reported a position in HHS in Q4 2013 and held it in 7 quarters. The position peaked at $414K in Q4 2013. 28 funds tracked by Wall St. Rank hold HHS as of Q1 2018.

  • RBF Capital reported no remaining Harte-Hanks position as of Q1 2018 after selling out during the quarter.
  • RBF Capital sold 3,229 Harte-Hanks shares in Q1 2018, an estimated $31K.
  • RBF Capital first reported a position in Harte-Hanks in Q4 2013 and held it in 7 quarters.
  • RBF Capital's Harte-Hanks position peaked at $414K in Q4 2013.
  • 28 funds tracked by Wall St. Rank held Harte-Hanks as of Q1 2018.

Based on RBF Capital's 13F filing for Q1 2018, filed 15 May 2018.